BACKGROUND: abdominoperineal resection for low rectal adenocarcinoma is a common procedure with high morbidity, including perineal wound complications.
that there are ≈40,000 cases of rectal cancer in the united states each year, and approximately one-fifth of these will require aPR. 6 even with aPR, the cure rate for patients with low rectal cancers is lower than for patients who undergo low anterior resections. [7] [8] [9] [10] Dissatisfaction with inferior cure rates has led surgeons to consider that a coned-in dissection during aPR may be associated with a high incidence of positive circumferential resection margin and tumor perforation. 11, 12 for that reason, they argue that wider, extralevator resections should be performed. Proponents of this technique report better results than with standard aPR. 13, 14 nevertheless, no prospective or randomized trials have tested this hypothesis. furthermore, the technique involves not just wider resection but also the use of either a vertical rectus abdominis myocutaneous (VRam) flap or a gracilis muscle flap to close the wound. 15 the addition of a flap closure to an aPR has been shown to decrease wound complications but not to alter survival. 16, 17 however, the bulk of evidence comes from studies on anal cancer. Patients with rectal cancer are different from those with anal cancer in that many require chemotherapy after their surgery. 18 Wound dehiscence can delay the initiation of chemotherapy. thus, any change in technique that alters the rates of postoperative infections might also change survival.
aPR is well recognized as having high morbidity, including perineal wound complications, which occur in ≤60% of cases. [19] [20] [21] [22] Wound dehiscence is a particularly difficult complication because it is unpleasant to the patient and requires expensive wound care. a perineal sinus can persist for months or even years. a number of studies have examined the risk factors for wound complications, but none have had wound dehiscence as the main focus or examined the effect of dehiscence on overall survival. [23] [24] [25] the aim of this study was to determine risk factors for postoperative wound dehiscence and to investigate the effect of wound dehiscence on survival.
MATERIALS AND METHODS

Participants and Study Design
Consecutive adult patients (age >18 years) undergoing aPR for low rectal adenocarcinoma performed between January 2001 and June 2012 at the massachusetts General hospital were identified through a search in the Partners Research Patient Data Registry. low rectal adenocarcinoma was defined as any tumor located <1 cm from the puborectalis or <5 cm from the anal verge and not considered by the operating surgeon to be a candidate for a sphincter-sparing surgery. Patients undergoing aPR for reasons other than adenocarcinoma (ie, squamous-cell carcinoma or iBD) were excluded. this study was reviewed and approved by the Partners institutional Review Board (protocol 2012-P-001456/1) with specific waiver of the need for individual patient consent.
Patient files were retrospectively reviewed, and pertinent demographic, oncologic, and surgical information was collected. study data were collected and managed using ReDCap electronic data capture tools hosted at Partners healthcare. 26 ReDCap is a secure, Web-based application for data capture for research studies, providing the following: 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for data downloads to common statistical packages; and 4) procedures for importing data from external sources. to allow for risk adjustment, a Charlson comorbidity index score was generated for each patient. 27 the Charlson comorbidity index predicts the 10-year mortality for a patient and is widely used to risk adjust patient populations.
Outcome Measures
Primary events after surgery included wound dehiscence and survival to death from any cause. Wound dehiscence was defined as separation of the skin at the perineal wound (partial or complete), regardless of the presence of infection. Wounds that were left open after surgery were excluded from the study. survival information was obtained from the Partners Research Patient Data Registry, which is linked with the social security Death index. Patients with no known death date were censored either at the end of the study period (august 1, 2012) or if records indicated that they left the country. secondary outcomes after surgery included urinary retention, urinary tract infection (uti), and superficial and deep-space wound infections. urinary retention was defined as the need for replacement of a urinary catheter after a failed postoperative voiding trial. uti was defined as a urine culture of >100,000 colonies per milliliter of urine with no more than 2 species of organisms. superficial wound infection was defined as purulent drainage from the superficial incision, pain or tenderness, localized swelling, erythema, or heat. Deep-space wound infection was defined as an infection involving any part of the anatomy (eg, organs or spaces) that was opened or manipulated during an operation other than the incision.
Statistical Analysis
Continuous and categorical variables are expressed as mean ± sD and proportions throughout the article, with the exception of continuous variables with grossly skewed distributions that are reported as the median with the interquartile range. Bivariate analysis of continuous and categorical variables was performed with logistic regression.
in multivariable analysis of risk factors for wound dehiscence, logistic regression was used. the model was constructed using a stepwise procedure (backwards Wald) with a p value of 0.20 to enter and 0.05 to eliminate variables. all of the variables were considered for inclusion in the model. for the survival analysis, comparison between patients who developed wound dehiscence and those who did not was performed using the log-rank test. to control for differences in patient characteristics, a Cox proportional hazard model was used. again, a stepwise procedure (backwards Wald) was used with a p value of 0.20 to enter and 0.05 to eliminate variables. age, Charlson score, and tumor stage were forced into the model, because all are known predictors of mortality. all of the other variables (with the exclusion of individual comorbidities, because they would be collinear with the Charlson score, and pathology data, because they would be collinear with tumor stage) were considered for inclusion in the model. sas statistical software (version 9.2; sas institutes inc, Cary, nC) was used for all analyses. all of the tests were 2 sided with an α level of 0.05.
RESULTS
Patient Characteristics a total of 249 patients underwent aPR for rectal adenocarcinoma during the study period. the mean age was 62.6 ± 14.4 years, and 63.8% were men (table 1). most of the patients were white (89.1%), and more than a quarter were obese (26.9%). the patients were mostly healthy with a mean Charlson score of 3.74 ± 2.40. in terms of oncologic history, 14.4% underwent resection for recurrence and 13.1% had metastases at the time of surgery. more than two thirds underwent preoperative chemotherapy (71.8%) and/or preoperative radiation (74.7%). for perioperative variables, 8.8% of the procedures were laparoscopically assisted, and the mean operative time was 268.9 ± 137.9 minutes (table 2). a total of 44.6% of patients underwent concurrent omental flap and/or omentopexy, and 3.6% had a VRam flap repair of the perineal wound. overall outcomes are displayed in table 3 . notably, urinary retention (20.1%), blood transfusion (18.9%), and uti (13.6%) were seen in >10% percent of cases. a total of 30.9% of patients experienced a wound complication. the incidence of superficial perineal wound infection was 10.8%, and only 4.4% of patients had a deep-space infection. sixty-nine patients (27.7%) experienced wound dehiscence. for those who experienced dehiscence, the median time to heal was 117 days, and the range was from 7 to 1096 days.
Surgical Outcomes
in a bivariate analysis of risk factors for wound dehiscence, the frequency of dehiscence was higher among patients with increased Bmi (oR, 1.06; 95% Ci, 1.01-1.11; p = 0.01), chronic obstructive pulmonary disease ((CoPD) oR, 3.2; 95% Ci, 1.1-9.3; p = 0.03), history of other malig-nant neoplasm (oR, 2.2; 95% Ci, 1.1-4.5; p = 0.03), and operative time greater than the median ((239 min) oR, 2.3; 95% Ci, 1.3-4.0; p = 0.01; table 4). in women only, the frequency of dehiscence was greater in those undergoing concomitant posterior vaginectomy (oR, 2.2; 95% Ci, 1.2-8.9; p = 0.02).
it was interesting that there were no significant differences between the 2 groups from an oncologic perspective. the frequency of dehiscence did not differ between patients who received neoadjuvant chemo/radiotherapy and those who did not, and there were no significant dif- ferences in the frequency of metastatic disease or stage. there was no difference in dehiscence frequency between those receiving intraoperative radiotherapy and those who did not. finally, dehiscence frequency was similar between those with R0 resection, circumferential resection margin < 5 mm, and positive nodes, and those without. in the multivariable model, increasing Bmi (oR, 1.09; 95% Ci, 1.03-1.15; p = 0.002), CoPD (oR, 5.8; 95% Ci, 1.9-18.0; p = 0.002), history of other malignant neoplasm (oR, 3.1; 95% Ci, 1.5-6.6; p = 0.01), iBD (oR, 6.6; 95% Ci, 1.4-32.5; p = 0.02), and aPR for recurrent rectal cancer (oR, 2.8; 95% Ci, 1.2-6.3; p = 0.02) were all associated with increased odds of wound dehiscence (table 4) .
Oncologic Outcomes and Survival
over the study period there were 70 deaths (28.1%). for patients who did not die, the median follow-up time was 45.3 months (range, 1.2-129.5 months). in the survival analysis, patients who experienced postoperative wound dehiscence had lower mean survival compared with those who did not (66.6 vs 76.6 months; log-rank p = 0.01; fig. 1 ). five-year survival in the postoperative dehiscence group was 47.3%, markedly lower than the 66.3% 5-year survival in the nondehiscence group. in the multivariable Cox proportional hazard model, perineal wound dehiscence was associated with a significantly increased hazard of death (hR, 1.7; 95% Ci, 1.1-2.8; p = 0.02; table 5).
DISCUSSION
Postoperative wound dehiscence, although unpleasant and costly, has traditionally been thought to have no effect on long-term survival. in this study of 249 patients undergoing aPR for rectal adenocarcinoma, increased Bmi, history of other malignant neoplasm, CoPD, iBD, and operating for recurrent disease were all associated with increased odds of postoperative perineal wound dehiscence. in turn, dehiscence was shown to have a significant association with increased mortality in a multivariable analysis.
this study has a number of strengths and weaknesses. the association between dehiscence and decreased survival is a novel one. in the bivariate analysis, the 2 groups were similar in terms of both preoperative and perioperative oncologic factors. With similar rates of metastasis at presentation, positive margins, positive nodes, intraoperative radiotherapy, and posterior vaginectomy in women, similar survival outcomes would be expected. instead, a marked difference in survival was found. this study attempted to control, via statistical analysis, for potential confounders such as age, increased comorbidity, and tumor stage, so that the occurrence of dehiscence was not simply a proxy for poor health. unfortunately, this study was unable to identify very many modifiable risk factors. other than advocating weight loss, there is little that clinicians can do to prevent wound dehiscence and its associated decrease in survival. several limitations deserve mention in this study. first, although this study used multivariable regression for both the occurrence of wound dehiscence and the subsequent effect on survival to reduce the biases inherent in observational studies, there could be hidden biases because our study only controlled for the observed variables. second, the study cohort was drawn from a single, tertiary care center with experienced colorectal surgeons. it may not accurately represent the universe of patients undergoing aPR.
other studies have examined wound healing after aPR. a high risk of wound infection after aPR has been well described. [19] [20] [21] 24, 25, 28 the wound complication rate in this study (30.8%) is comparable to those found by Bullard et al (41.0%), 28 artioukh et al (26.0%), 19 and Chessin et al (37.2%). 20 similarly, the rate of dehiscence in this study (27.7%) parallels the findings of Bullard et al (24%), 28 artioukh et al (22.5%), 19 and Butler et al (22.5%). 21 the perineal wound is particular vulnerable to breakdown because of factors such as preoperative radiation, tension, and its location in a dirty area. multiple risk factors for wound complications have been identified. there is a consensus that neoadjuvant chemoradiation is a major risk factor for poor wound outcomes in the perineum after aPR. 23, 28, 29 it is interesting that this study found only a nonsignificant trend toward increased dehiscence in patients who underwent chemoradiation therapy. this is perhaps because a high proportion of our patients underwent neoadjuvant chemoradiation. similarly, obesity and smoking are associated with increased wound complications after aPR. 25, 30 our analysis supported an association with obesity but not smoking. overall, a strength of this study is the examination of the long-term survival effects of wound dehiscence, which have not been examined previously.
the known risk of perineal wound issues has generated many techniques for closing the perineal wound. in his original article, miles 31 open, packed, and allowed to heal by secondary intention. although this approach might avoid some complications of primary closure, it is a great discomfort and an inconvenience for the patient. the use of omental pedicle flaps has been well described, although with conflicting results. studies have reported decreased risk of dehiscence 32 and improved wound healing. 33, 34 other studies have documented no benefit. 35, 36 the findings in this study support no difference in wound dehiscence with or without an omental flap. more recently, muscle flap closure has shown great promise. lefevre et al 16 demonstrated decreased morbidity and reduced healing time with the use of a VRam flap in patients undergoing aPR for anal cancer. in considering the association between dehiscence and survival, one possible explanation is that perineal wound dehiscence would delay postoperative chemotherapy. Because postoperative chemotherapy is the standard of care to prevent local and distant recurrence, any delay could have a negative effect on survival. 18, 37 We believe that this study brings to light the importance of wound dehiscence after aPR for rectal adenocarcinoma with significant implications for clinicians. Perineal wound dehiscence will only become more of an issue as surgeons move toward more aggressive, extralevator aPR. 13, 38 We question whether the survival benefit seen in extralevator aPR is truly from the wider resection or instead from the fact that most of these patients receive flap coverage of their perineal wound with subsequent decreased wound complications and a shorter interval to postoperative chemotherapy. in future trials, the use of flap coverage is an important factor that needs to be taken into account. further prospective or randomized, controlled studies using muscle flap closure will hopefully elucidate the best practice for minimizing wound dehiscence. included in these studies should be detailed information about the effect of postoperative chemotherapy. this is a question unable to be answered from this study. for now, we recommend increased surveillance and careful wound care for high-risk patients as identified in this study.
CONCLUSION
the adjusted risk of death was 1.7 times higher in patients who experienced dehiscence than in those who did not. attention to perineal wound closure with consideration of flap creation should at least be given to patients with a history of malignant neoplasm, those with iBD, those with rectal cancer recurrence, and women undergoing posterior vaginectomy. Preoperative weight loss should also reduce dehiscence risk.
